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H4K16 acetylation marks active genes and enhancers
of embryonic stem cells, but does not alter chromatin
compaction
Gillian C.A. Taylor, Ragnhild Eskeland,1 Betu¨l Hekimoglu-Balkan, MadapuraM. Pradeepa,2
and Wendy A. Bickmore2
MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine at University of Edinburgh, Edinburgh EH4 2XU,
United Kingdom
Compared with histone H3, acetylation of H4 tails has not been well studied, especially in mammalian cells. Yet, H4K16
acetylation is of particular interest because of its ability to decompact nucleosomes in vitro and its involvement in dosage
compensation in flies. Here we show that, surprisingly, loss of H4K16 acetylation does not alter higher-order chromatin
compaction in vivo in mouse embryonic stem cells (ESCs). As well as peaks of acetylated H4K16 and KAT8 histone
acetyltransferase at the transcription start sites of expressed genes, we report that acetylation of H4K16 is a new marker of
active enhancers in ESCs and that some enhancers are marked by H3K4me1, KAT8, and H4K16ac, but not by acetylated
H3K27 or EP300, suggesting that they are novel EP300 independent regulatory elements. Our data suggest a broad role
for different histone acetylation marks and for different histone acetyltransferases in long-range gene regulation.
[Supplemental material is available for this article.]
Histone acetylation has long been associated with gene expres-
sion. Unlike histone methylation, where modification of different
H3 residues is associated with distinct functions and mediated by
different methyltransferases, histone lysine acetyltransferases
(HATs) often seem to have a fairly broad substrate specificity and
can modify a number of different lysine residues in histones and
nonhistone proteins (Peterson and Laniel 2004). Mutagenesis
suggests that there is functional redundancy between most of the
different acetylatable lysines in the H3 and H4 tails in budding
yeast (Mann and Grunstein 1992; Dion et al. 2005). Consistent
with this, there is a high degree of correlation between the acety-
lation state of a particular residue and most of the other lysine
residues in core histones (Millar et al. 2004). The outlier in that
analysis is H4K16—acetylation of which correlated poorly with
that of other lysines in histones. Acetylation of histoneH4 on lysine
16 (H4K16ac) is also especially important for chromatin structure
and function in a variety of eukaryotes (Dion et al. 2005) and is
catalyzed by specific HATs (Millar et al. 2004).
Histone acetylation influences chromatin structure in several
ways. It can provide a platform for the binding of proteins that
contain domains which recognize acetylated lysine residues. Sec-
ondly, it can block the function of chromatin remodellers (Corona
et al. 2002). Thirdly, and most directly, it neutralizes the positive
charge on lysines. H4K16 is particularly interesting from this point
of view: It is the only acetylatable residue in the basic patch of
the H4 N-terminal tail (Dorigo et al. 2003), and by contacting
the acidic patch of H2A/H2B in adjacent nucleosomes it can direct
the formation of a compact higher-order chromatin structure in
vitro (Dorigo et al. 2004; Shogren-Knaak et al. 2006; Robinson
et al. 2008). Conversely, by blocking the binding of the e-amino
group of K16 to a site on H2B in an adjacent nucleosome, acety-
lation of H4K16 weakens the nucleosome–nucleosome stacking
and the self-association of nucleosome core particles (Allahverdi
et al. 2011; Liu et al. 2011). Consistent with these in vitro data,
deacetylation of H4K16 is important in heterochromatin formation
in budding yeast (Millar et al. 2004).
In Drosophila, H4K16 acetylation is targeted to the X chro-
mosome of male flies and is important for dosage compensation
(Bone et al. 1994). Indeed, the puffed appearance of theDrosophila
hyperactive male X chromosome is consistent with H4K16ac
leading to chromatin decondensation in vivo. The enzyme
responsible for this H4K16 acetylation is the MYST-family HAT
MOF that functions in dosage compensation as part of the MSL
complex.
MOF is found at both the 59 and 39 ends of genes on the
dosage-compensated X chromosome of male flies. However, else-
where in the genome and in female flies MOF is located mainly at
the 59 end of active genes, and its binding there is independent of
the MSL complex. Consistent with this, peaks of H4K16ac are
found toward the 59 end of transcriptionally active autosomal
genes, whereas a broad domain of H4K16ac is found across dosage-
compensated genes in male flies (Kind et al. 2008).
It is unclear towhat extentMOF is theHATresponsible for the
59 peak of H4K16ac at autosomal genes (Gelbart et al. 2009). In
flies, MOF is also found in a complex distinct from MSL—the
nonspecific lethal (NSL) complex, which contains the MSL1-like
proteins NSL1, NSL2, NSL3, MCRS2, MBD-R2, and WDR5 (Raja
et al. 2010).WDR5 is also part of compass-likeH3K4me3 complexes.
NSL targets MOF to the 59 end of genes in flies (Prestel et al. 2010;
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Feller et al. 2011), where it is suggested to regulate the expression of
housekeeping genes (Lam et al. 2012).
NSL is also present in mammalian cells and is responsible for
most of the H4K16 acetylation (Smith et al. 2005; Taipale et al.
2005). KAT8, the mammalian homolog of MOF, has been detected
by chromatin immunoprecipitation (ChIP) at the promoters and
transcribed regions of active genes in human CD4+ T cells and in
mouse embryonic stemcells (ESCs) (Wang et al. 2009; Li et al. 2012).
Interestingly, although many HATs, e.g., Kat5, EP300 (p300), and
Kat2a, have little effect on pluripotency, but mainly affect ESC dif-
ferentiation (Lin et al. 2007; Fazzio et al. 2008; Zhong and Jin 2009),
Kat8 deletion leads to loss of ESC self-renewal (Li et al. 2012).
Many histone acetylation residues have been mapped ge-
nome wide by ChIP in a wide variety of mammalian cell types as
part of the ENCODE and Roadmap Epigenomics Project. Sur-
prisingly, given its particular significance for chromatin structure,
H4K16ac is not among those histone modifications that have
been analyzed extensively in this way. Here we use native ChIP to
determine the genome-wide distribution of H4K16ac in undiffer-
entiated and differentiatedmouse ESCs, andwe use fluorescence in
situ hybridization (FISH) to detect any changes in the in vivo
chromatin compaction state at pluripotency loci that lose exten-
sive H4K16ac domains during differentiation. Our data suggest
a novel role for KAT8 and H4K16ac in long-range gene regulation
and reveal a new class of enhancers in ESCs
Results
H4K16 acetylation is enriched around the transcriptional start
site of active genes in ESCs
To determine the genome-wide distribution of H4K16 acetylation
we performed native ChIP with an antibody detecting H4K16ac
in undifferentiated mouse 46c ESCs. The specificity of the anti-
H4K16ac antibodywas confirmedwith amodified histone peptide
array (Pradeepa et al. 2012; Supplemental Fig. S1A). Immunopre-
cipitated DNA was assessed by high-throughput sequencing. To
examine the global profile of H4K16ac around transcribed regions,
we created tag density counts (reads per million/RPM) for 5-kb
regions surrounding either the transcriptional start site (TSS) or the
transcription end site (TES) and for percentile regions across gene
bodies (with 62-kb regions in 200-bp windows). This was com-
pared across quartiles of gene expression, from high gene expres-
sion (Q1) to low expression (Q4), as ascertained by expression
profiling (Fig. 1A).
A peak of H4K16ac was seen around the TSS of active genes,
which is greatest at the most active genes, consistent with the
pattern of H4K16ac reported previously inCD4+Tcells (Wang et al.
2008). This result was confirmed in an independent (OS25) ESC
line (Supplemental Fig. S1B). There is no H4K16ac around the TES.
The distribution pattern of H4K16ac is typified by the profiles
across the active beta actin (Actb) (Fig. 1B) and Calm1 (Supple-
mental Fig. S1C) genes, where peaks of H4K16ac occur at the
promoters/59 ends, and by the absence of H4K16ac at Ifng, which is
silent in ES cells (Fig. 1B). The same distribution patterns are also
seen when immunoprecipitated DNA was analyzed on genomic
microarrays (Fig. 1B; Eskeland et al. 2010a).
To examine the localization of H4K16ac across genes and
regulatory regions more closely, we generated RPM per base pair
(RPM/bp) profiles for averaged gene bodies and for 2-kb windows
upstreamof the TSS and downstream from the TES. Themajority of
H4K16ac is located on active promoters, up to 2 kb upstreamof the
TSS, and extends ;20%–30% into the body of the gene, but is
not enriched at the 39 end of the coding region or after the TES
(Fig. 1C). H4K16ac distribution on the promoters of active genes is
similar to that of H3K4me3, but is broader, with peaks of almost
equal height centered over the +1 and 1 nucleosomes, whereas
H3K4me3 peaks asymmetrically over the +1 position. H4K16ac
also spreads further into the gene body compared with H3K4me3,
but its distribution differs from that of H3K36me3, a histone
modification associated with the elongation of transcription and
enriched on the gene bodies of active genes (Fig. 1C). The asso-
ciation of H4K16ac with active genes is consistent with the re-
quirement for KAT8 for expression of the pluripotency network in
ESCs (Li et al. 2012).
We analyzed the distribution of H4K16ac peaks over nine
categories of genomic region (detailed in Fig. 1D, right). The ma-
jority of H4K16ac peaks fall within genic regions, but large pro-
portions are also found 10 kb upstream of TSS or downstream from
TES. By comparison with H3K4me3, a much lower proportion of
H4K16ac peaks fall immediately over the TSS (1000 in Fig. 1D).
The profile of H4K16ac shares more similarity with H3K27ac (see
below).
H4K16ac changes during the differentiation of ES cells
In Drosophila, the MOF/NSL complex is thought to be associated
with housekeeping genes; however, KAT8 is required for murine
development (Gupta et al. 2008; Thomas et al. 2008; Li et al. 2012),
suggesting that H4K16ac may be associated with developmentally
regulated gene expression. In order to investigate this we differ-
entiated 46c ESCs into neural progenitor cells (NPCs) and purified
the Sox1-GFP-expressing NPCs by fluorescence-activated cell sort-
ing (FACS). Differentiation was also confirmed by expression
microarrays: GO term analysis of up-regulated genes showed an
enrichment of terms for neuronal genes. We performed native
ChIP sequencing in ESC and NPCs, and the levels of H4K16ac
across the TSS of all genes was separated by expression into four
quartiles. Surprisingly, this revealed that, unlike in ESCs, there is
no significant enrichment of H4K16ac around TSS compared with
input, and no relationship to gene expression levels in NPCs (Fig.
2A). Western blot showed that this does not simply reflect a global
loss of H4K16ac upon NPC differentiation, which has been
reported during later stages of embryoid body or retinoic acid (RA)-
induced ESC differentiation (Fig. 2B; Li et al. 2012).
Genes that lose expression upon differentiation to NPCs (e.g.,
Tcl1) lose peaks ofH4K16ac around their promoters (Fig. 2C). Some
genes that retain similar levels of expression between ESCs and
NPCs (e.g., Actb) still retain a small peak of H4K16ac over their
promoter (Fig. 2D), though this is much reduced, and is not true
of all genes in this class. This was also confirmed by ChIP-chip
(Fig. 2D). However, genes that gain expression upon differentia-
tion to NPCs (e.g., Foxb1 in Fig. 2E) do not generally gain a peak of
H4K16ac in NPCs.
To determine how H4K16ac changes genome wide, we used
the expression profiles from undifferentiated (UD) ESCs and dif-
ferentiated NPC cells to determine genes that have higher ex-
pression in UD than in NPC, and conversely genes whose ex-
pression increases during the differentiation to NPCs. In UD cells,
there is a clear difference between these two classes of genes;
levels of H4K16ac are much greater on genes that are more highly
expressed UD ESCs than in NPCs. However, in NPCs, there is little
difference in average levels of H4K16ac between the two gene
classes (Fig. 2F).
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Figure 1. Profile of H4K16 acetylation in undifferentiated ESCs. (A) Input normalized (average reads per million/RPM) H4K16ac native ChIP-seq tag
counts around (65 kb) the transcription start site (TSS) and transcription end site (TES) of genes separated into quartiles according to expression in ESC
from high to low (Q1–Q4). (B, top) H4K16ac/H3K27ac/H3K4me3 profiles (RPM/bp), in 200-bp sliding windows with a 20-bp step, across the Actb (active)
and Ifng (silent) loci. Exons are shown as boxes below the graph, and the direction of transcription is indicated. (Bottom) Log2 H4K16ac/input at Actb and
Ifng established by hybridization of H4K16ac ChIP DNA to a custom microarray. (C ) Average RPM/bp tag counts across gene bodies for 500 active (left)
and inactive (right) genes (in intervals of 10%of gene length) and extending 2 kb upstreamof the TSS, and 2 kb downstream (in 200-bp intervals). Data are
for H4K16ac (blue), H3K4me3 (pink), and H3K36me3 (green). (D) Genomic distribution of H4K16ac, H3K27ac, andH3K4me3 peaks in ESCs, and 0.53 106
peaks randomly distributed throughout the genome. (Left) Percentage of histone modification peaks found across each category of genomic sequence,
relative to mm9 RefSeq genes. (Right) Schematic detailing the categorization (peaks classified as distal intergenic do not fall into any of the previous
categories).
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Figure 2. Gain and loss of H4K16 acetylation during ESC differentiation. (A) Normalized (average reads per million/RPM) H4K16ac (solid lines) or input
(dotted lines) ChIP-seq tag counts around (65 kb) the transcription start site (TSS) and transcription end site (TES) of genes separated into quartiles according to
expression in ESC (left) orNPC (right) (fromhigh to low [Q1–Q4]). (B)Westernblot ofH4K16ac in undifferentiatedOS25 ESC,OS25cells after 3dof differentiation
using retinoic acid (lanes 1 and 2), undifferentiated 46c ESC, andNPCs (lanes 3 and 4). Levels of H3 are shown for comparison. (C ) UDH4K16ac, UD input, NPC
H4K16ac, andNPC input profiles (RPM/bp), in 200-bp slidingwindowswith a 20-bp step, across the Tcl1 locus, which is silenced uponNPCdifferentiation. Exons
are shownasboxesbelow thegraph and thedirectionof transcription is indicated. (D) As inC, across theActb locus, thismaintains similarly high levels of expression
inUDESC andNPCs. At the bottom, log2H4K16ac/input is shown atActb established by hybridization to a custommicroarray of ChIPDNA from46c ESC and 46c
NPC. Chromosomeposition and RefSeq gene annotations are used from July 2007 (mm9)mouse genomebuild (UCSC). (E) As inC, across the Foxb1 locus, this is
silent in ESC, and highly expressed in NPCs. (F) RPM H4K16ac (solid lines) or input (dotted lines) ChIP-seq tag counts around (65 kb) the TSS of genes
differentially up-regulated in either ESC (ESC up genes, green lines) or NPC (NPC up genes, red lines). Data are shown for ESC (left) and NPC (right).
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Figure 4. (Legend on next page)
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We performed the same analysis on ESCs differentiated for
3 d (D3) with RA. This revealed a similar reduction in H4K16ac
peak height over active genes during differentiation, though here,
active genes in the differentiated cell population could still be
distinguished from inactive genes by H4K16ac tag density (Sup-
plemental Fig. S2A). Similarly, genes that gained in expression in
D3 cells showed modestly higher H4K16ac than genes that were
more highly expressed in UD cells (Supplemental Fig. S2B). Addi-
tionally, Hox genes that are activated during RA-induced differen-
tiation show a clear increase of H4K16ac during differentiation
(Supplemental Fig. S2C).
H4K16 acetylation does not impact upon large-scale chromatin
compaction
In vitro, acetylation of H4K16 has been shown to result in a loss of
nucleosome–nucleosome interactions and a disruption of chroma-
tin compaction in vitro (Dorigo et al. 2004; Shogren-Knaak et al.
2006; Robinson et al. 2008; Liu et al. 2011). The gross chromatin
compaction defects reported in Kat8-deficient murine ESCs (Li et al.
2012) would be consistent with H4K16ac leading to chromatin
decompaction in vivo. However, a direct role of H4K16ac in chro-
matin decompaction at specific loci has not been tested in vivo in
mammalian cells.
To determine directly whether large domains of H4K16ac,
and their loss during differentiation, correlate with visible changes
in chromatin compaction, we analyzed genomic regions at which
H4K16ac is spread over large (>100 kb) genomic domains, rather
than in discrete promoter-associated peaks, in undifferentiated
ESCs, and where it is lost from these regions upon differentiation.
The regions chosen for analysis were those encompassing Nanog
and the adjacent pluripotency gene Dppa3, and Sox2 (Fig. 3A). To
assay chromatin compaction, we used FISH with pairs of probes
90–150 kb apart from each other (Fig. 3B). The mean-squared in-
terprobe distance (d2) has a linear relationship with genomic sep-
aration (kb) over this size range and can be used to both measure
changes in chromatin compaction during development and ESC
differentiation (Chambeyron and Bickmore 2004; Morey et al.
2007). Moreover, such analysis can determine the role of specific
epigenetic pathways and histone modifications in chromatin
compaction (Eskeland et al. 2010a). Indeed, in this way we have
previously demonstrated a role for polycomb repressive complexes
in compacting chromatin, and a general role for elevated histone
acetylation, induced by inhibiting class I and class II histone
deactylases, in decompacting higher-order chromatin structure at
polycomb-repressed regions (Eskeland et al. 2010a,b). Normaliza-
tion to nuclear size (nuclear radius squared: r2) takes into account
any global changes in the nuclear area between cell types.
Surprisingly, we detected no significant increase in chromatin
compaction around theNanog (P = 0.91) and Sox2 (P = 0.35) loci, as
H4K16ac domains are lost from these regions during ESC differ-
entiation (Fig. 3C). We therefore conclude that H4K16ac is not
simply linked to the levels of higher-order chromatin compaction
that are assayable by FISH.
H4K16 acetylation marks active enhancers in embryonic
stem cells
While profiling the genome-wide location of H4K16ac peaks, we
noticed that a proportion fell into intergenic locations and that the
overall genomic distribution of H4K16ac is rather similar to that
of H3K27ac (Fig. 1D). Given that previous studies have established
certain histone modifications, including H3K27ac, as predictive
factors for regulatory regions such as enhancers (Roh et al. 2005;
Heintzman et al. 2007; Creyghton et al. 2010; Rada-Iglesias et al.
2011), we reasoned that the intergenic peaks of H4K16ac may
predict enhancers. Indeed, a peak of H4K16ac downstream from
Klf4 in ES cells (Supplemental Fig. S1E) seems to locate at the cis-
regulatory sequence that corresponds to a DNase I hypersensitive
site (DHS) in the UCSCGenome Browser, which has been reported
to be marked by H3K4me1 (a mark considered indicative of both
active and inactive enhancers), H3K27ac, and EP300 in ES cells
(Shen et al. 2012).
To investigate this more widely, we identified active and in-
active enhancers in ESCs by previously established criteria, using
publicly available genome-wide ChIP-seq data for H3K4me1 and
H3K27ac (Creyghton et al. 2010; Rada-Iglesias et al. 2011). The
H4K16ac profile over active enhancers is very similar to that of
H3K27ac (Fig. 4A), and enhancers generally defined as active
(H3K4me1+/H3K27ac+) have considerably more H4K16ac than
inactive ones (H3K4me1+/H3K27ac) (Fig. 4B). H3K4me3, which
is known to mark promoters rather than enhancers (Rada-Iglesias
et al. 2011), andMNase digested input DNA, were used as negative
controls.
At the genetically defined ESC active enhancer for Igll1/
lambda5 (Liber et al. 2010), located between the Igll1 and Vpreb1
genes, there is no H3K4me3, but there is a peak of H4K16ac along
with the previously defined enhancer marks, H3K4me1 and
H3K27ac, in the Igll1–Vpreb1 intergenic region, coincident with
a DHS. (Fig. 4C). Conversely, at theMnx1 locus, the inactive motor
neuron specific enhancer (Nakano et al. 2005) is marked by
H3K4me1, but not H4K16ac or H3K27ac.
Globally, H4K16ac tag density and peak width are higher on
promoters compared with enhancers, but at most pluripotency
genes the H4K16ac level on enhancers is as high as it is on the
promoters of these genes (Supplemental Fig. S3).
We noticed that a number of enhancers with lower levels of
H3K27ac showed little to no H4K16ac in ESCs, while other en-
hancers defined as ‘‘inactive’’ due to their lack of H3K27ac showed
H4K16ac. This suggests that some enhancers may be marked as
Figure 4. H4K16ac is found on active enhancers. (A,B) Heatmaps of H4K16ac, H3K27ac, H3K4me1, H3K4me3, and input ChIP-seq data (RPM) at
H3K4me1+/H3K27ac+ (A), and H3K4me1+/H3K27ac (B) marked enhancers. Data are ranked by sum of hits in the H4K16ac data set; 10-kb window
around enhancer midpoint, in 500-bp windows. Intensity is determined by RPM. (C ) Histone modification profiles and DNase I hypersensitive sites (DHS)
across (top) a genetically defined enhancer active in ES cells (Igll1-Vpreb1 loci) and (bottom) a neuron-specific enhancer (atMnx1 locus) not active in ESCs.
Purple box indicates the likely enhancer location. Histone modifications are shown as RPM/bp in 200-bp sliding windows with 20-bp step, DHS sites are
shown as tag density in a 150-bp window with a 20-bp step. (D) Quantification of SICER defined H3K27ac+/H3K4me1+/H3K4me3-, and H4K16ac+/
H3K4me1+/H3K4me3- peak overlap. Venn diagram illustrates number of clustered active enhancers marked by H4K16ac or H3K27ac alone, or both
together. (E) Profiles of H4K16ac, H3K27ac, H3K4me1, and H3K4me3, at an example of an H4K16ac+/H3K27ac-/H3K4me1+ putative active enhancer.
Histone modifications and DHS sites shown as in C. (F) Heatmaps of H4K16ac, H3K27ac, H3K4me1, H3K4me3, and input ChIP-seq data (RPM) at
H3K4me1+/H3K27ac+ (top), and H3K4me1+/H3K27ac (bottom) marked enhancers in NPCs. Data are ranked by sum of hits in the H3K27ac data set;
10-kb window around enhancer midpoint, in 500-bp windows. Intensity is determined by RPM. (G) Profiles of NPC H4K16ac, H3K27ac, H3K4me1, and
H3K4me3, as an example of an enhancer active in neuronal cell types (Antonellis et al. 2008). Histone modifications and DHS sites shown as in C.
H4K16 acetylation and long-range genome regulation
Genome Research 2059
www.genome.org
 Cold Spring Harbor Laboratory Press on October 16, 2015 - Published by genome.cshlp.orgDownloaded from 
active by one histone acetylation mark or the other. To quantify
this, we defined distal H3K4me1+/H3K4me3 regions that over-
lapped either H3K27ac or H4K16ac, giving a total of 16,947 puta-
tively active enhancers. A total of 37% of these regions overlap, but
2180 regions are unique to H4K16ac and 8420 are unique to
H3K27ac (Fig. 4D). Of the 2180H3K27ac independent regions, 74%
are also acetylated at H4K16 in the rep-
licate data set from an independent ES
cell line. The number of H4K16ac+/
H3K27ac regions was significantly en-
riched at enhancers compared with the
genome-wide level (P < 0.01, Fisher’s
exact test). An example of an H4K16ac+/
H3K4me1+/H3K27ac region at the Sgsm1
locus is shown in Figure 4E.
Finally, we wanted to examine
whether the presence of H4K16ac on ac-
tive enhancers was also a feature of dif-
ferentiated cells. We therefore identified
active and inactive enhancers using pub-
licly available data for H3K4me1 and
H3K27ac in NPCs (Meissner et al. 2008;
Creyghton et al. 2010). We do not find
that H4K16ac is present on active or in-
active enhancers in this cell type (Fig. 4F).
In addition, we looked at the NPC his-
tonemodification profile of a genetically
defined active neural Sox10 enhancer
(Antonellis et al. 2008). The region shows
clear peaks ofH3K27ac andH3K4me1, but
has no enrichment of H4K16ac (Fig. 4G).
H4K16ac and KAT8 define a class of
enhancers independent of H3K27ac
and EP300
Although most H4K16 acetylation is
thought to be mediated by KAT8 (Smith
et al. 2005; Taipale et al. 2005; Li et al.
2012), it is possible that other enhancer-
localized HATs, such as EP300, could
catalyze H4K16ac at regulatory regions.
Therefore, we used publicly available
ChIP-seq data (Wang et al. 2008; Li et al.
2012) to compare KAT8 and EP300 bind-
ing profiles across the ES cell genome.
As expected from the H4K16ac pro-
file, and similar to EP300, KAT8 shows a
much higher peak over the TSS of active
genes than for inactive genes (Fig. 5A).
Moreover, like EP300, KAT8 is also gen-
erally enriched around enhancers defined
as active (H3K27ac+), but not inactive
(H3K27ac) (P < 2.2 3 1016 for KAT8
and EP300) (Fig. 5B). Genomewide, peaks
of H4K16ac have a greater overlap with
KAT8 (71%) thanwith EP300 (58%), with
53% of H4K16ac peaks overlapping both
HATs (Fig. 5C). A small number of KAT8
independent H4K16ac peaks are over-
lapped by EP300 (5%), compared with
18% of EP300 independent H4K16ac
peaks that overlap KAT8. However, the
lower sequencing depth of the EP300 data
set may result in some false negatives.Figure 5. (Legend on next page)
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In some cases, for example, the intragenic enhancer in Kndc1 up-
stream of Utf1, KAT8 binding mirrors the profile of H4K16ac,
H3K27ac, and H3K4me1 better than does EP300 (Fig. 5D).
There is also a small enrichment of KAT8 over enhancers that
would have been defined as inactive based upon the absence of
H3K27ac-defined peaks. Figure 5E shows an example of a KAT8
peak in an intron of Emid1, which overlaps peaks of H4K16ac and
H3K4me1 and a DHS, whereas an EP300 peak was not detected,
and the level of H3K27ac does not reach the threshold for peak
calling.
To demonstrate the enhancer function of KAT8 bound/
H4K16 acetylated regulatory regions, we cloned regions with peaks
of H4K16ac and H3K4me1, but not H3K27ac, into a luciferase re-
porter vector with a minimal promoter. As a positive control, the
genetically defined (Jiang et al. 2008) ESC enhancer ofNanog (gray-
shaded box in Fig. 6A) was used. The H3K4me1+/H4K16ac+/
H3K27ac regulatory region downstream fromGsx2 (AE3) and the
enhancer at the 39 end of Otop3 (AE4) are shown as examples of
other tested regions (Fig. 6B,C). Regions with H3K4me1, but not
H3K27ac or H4K16ac, were used as negative controls. The Nanog
enhancer and all four tested distal regulatory regions that are
H4K16ac+/ H3K27ac had two- to 28-fold higher luciferase ac-
tivity in ESCs compared with the plasmid control. Regions with
H3K4me1 peaks but not H3K27ac or H4K16ac show no activity
(Fig. 6D). Therefore, we conclude that KAT8-mediated H4K16
acetylation may mark a new set of long-range regulatory elements
in mammalian ESCs.
Discussion
We find a high H4K16ac level around the transcription start sites
(TSS) of expressed genes in mouse ESCs (Fig. 1). Upon differenti-
ation, H4K16ac is reduced at TSS, although the global abundance
of this histonemodification seems unchanged (Fig. 2). Few specific
genes gainH4K16ac during differentiation:Hox genes appearing to
be an exception (Supplemental Fig. S2). The genomic sites that
gain H4K16ac upon differentiation of ESCs remains unclear. There
may be a general redistribution across the genome so that there are
no longer many ‘‘peaks’’ of H4K16ac evident, or there may be a
redistribution toward repetitive elements. Our preliminary analy-
sis suggests that there may be some redistribution toward intronic
sequences, but this will require further investigation (Supple-
mental Fig. S2D).
The enrichment of H4K16ac and KAT8 that we have found at
the TSS of active genes in ES cells is similar to that reported forMOF
in the context of the NSL complex in femaleDrosophila and on the
autosomes (i.e., nondosage-compensated chromosomes) of male
flies (Gelbart et al. 2009; Lam et al. 2012). We find no evidence for
increased H4K16ac at the 39 ends of mammalian genes, which
is unlike the situation on the dosage-compensated Drosophila X
chromosome (Kind et al. 2008). The gene-body enrichment of
H4K16ac (Fig. 1D) and KAT8 (Li et al. 2012) suggest a possible role
in transcriptional elongation in mammals, as has been proposed
for the Drosophila MOF-containing MSL complex (Larschan et al.
2011).
KAT8 has been biochemically purifiedwith several complexes
associated with H3K4 methyltranferase activity—either directly
with MLL1 (Dou et al. 2005) or in the context of the NSL complex
(Cai et al. 2010) together withWDR5—which is required for global
H3K4me3 (Wysocka et al. 2005) and is also found in MLL/SET
COMPASS complexes. Histone tail cross-talk between the KAT8–
MSL complex and H3K4me3 has also been reported (Wu et al.
2011). However, we find that the distributions of H4K16ac and
H3K4me3 around the TSS of active genes are distinct. Whereas
H3K4me3 is much higher on the +1 nucleosome than the 1,
H4K16ac is more symmetrically distributed on these two nucleo-
somes surrounding the nucleosome free region (Fig. 1C). H3K4me3
is also generally absent from regulatory domains, indicating that
at these sites, KAT8 is unlikely to be in complexes associated
with H3K4me3 activity, or that the catalytic activity of the H3K4
methyltransferase is altered in such contexts, or that an H3K4me3
demethylase activity is in operation.
Although there is substantial evidence for a direct role of
H4K16ac in reducing levels of chromatin compactionmediated by
nucleosome–nucleosome interactions in vitro (Dorigo et al. 2004;
Shogren-Knaak et al. 2006; Robinson et al. 2008; Allahverdi et al.
2011; Liu et al. 2011), we did not detect any visible changes in
higher-order chromatin compaction in vivo at loci (Nanog and
Sox2), where large domains of H4K16ac are lost upon ESC differ-
entiation (Fig. 3). However, we cannot rule out a role for H4K16ac
in decompaction of chromatin at a smaller local nucleosomal level
that is not amenable to analysis by FISH. Since H4K16 has been
shown to be important in mediating interactions between adja-
cent nucleosomes (Allahverdi et al. 2011; Liu et al. 2011), we
suggest that the levels of chromatin compaction that can be
assayed by FISH may instead be due to interactions between
chromatin fibers. Our data suggest that the grossly aberrant chro-
matin compaction apparent in Kat8-deficient embryos and ESCs
(Thomas et al. 2008; Li et al. 2012)may be an indirect effect of pan-
cellular loss of this important factor, rather than a direct conse-
quence of the loss of H4K16ac on chromatin compaction.
Surprisingly, like H3K27ac, we found that H4K16ac is en-
riched on active, but not inactive enhancers in ESCs (Figs. 4, 5).
H3K27ac has generally been considered to be catalyzed by EP300
( Jin et al. 2011). However, we found enhancer-like elements where
the KAT8 distribution more closely mirrors that of the H3K27ac
than does EP300 (Fig. 5D,E). At these sites H3K27ac may therefore
be catalyzed by another HAT (such as CREBBP/CBP), or by KAT8 in
a context inwhich its substrate specificity
has been relaxed (Cai et al. 2010).
Creyghton et al. (2010) suggested the
existence of H3K27ac marked enhancers
devoid of H3K4me1 (18% of H3K27ac
peaks >2 kb from a TSS). Similarly, we
found that in ESCs 59% of similarly distal
H4K16ac peaks are devoid of H3K4me1.
Importantly, we also found some co-
occurrence of H3K4me1-modified regu-
latory elements with H4K16ac, but not
H3K27ac, suggesting that these regions
could be novel enhancers in ESCsmarked
Figure 5. KAT8 is found on active enhancers. (A) RPM cross-linked ChIP-seq tag counts from ESCs
around (65 kb) the TSS and TES of active (green) and inactive (red) genes for KAT8 (left) and EP300
(right). (B) Average RPM per enhancer tag counts around the enhancer midpoint of active (H3K4me1+/
H3K27ac+) or inactive enhancers for KAT8 (left) or EP300 (right) ChIP-seq (solid lines) or for input DNAs
(dotted lines). (C ) Quantification of SICER defined H4K16ac, KAT8, and EP300 peak overlap. Venn
diagrams from left to right illustrate number of peaks overlapping between H4K16ac/KAT8, H4K16ac/
EP300, and KAT8/EP300, respectively. (D) H4K16ac/KAT8/EP300/H3K27ac/ H3K4me1/ and H3K4me3
ChIP profiles from ESCs around the Kndc1-Utf1 locus. Data are shown as RPM per base pair (bp) in 200-bp
sliding windows with a 20-bp step. Purple-shaded boxes indicate regions where the KAT8 distribution
more closely mirrors that of H3K27ac than does EP300. (E) H4K16ac/KAT8/H3K27ac/EP300/H3K4me1/
input andDHSprofiles fromESCs across a potentially H4K16ac-specific active enhancer in the Emid1 locus.
The peak of H4K16ac and KAT8 (purple-shaded area) corresponds to a strong DHS and a peak of
H3K4me1, but not of EP300/H3K27ac.
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by KAT8-mediated H4K16ac, but not EP300-mediated H3K27ac
(Fig. 6B,C). We validated five of these newly identified sites and
found that they are indeed functionally active regulatory elements
in reporter assays in ESCs (Fig. 6D).
We suggest that H4K16ac represents a new marker of ac-
tive enhancers in ESCs, which can be independent of H3K27ac.
As H4K16ac is a very abundant his-
tone modification in some cell types, it
is unlikely to make an efficient/specific
marker for enhancers in its own right,
but only in combination with other
histone modifications or the presence
of specific DNA-bindingproteins.Wenote
that H3K9K14ac was reported at the Igll1/
lambda5 enhancer (Szutorisz et al. 2005)
in ESCs, and also that a recently stud-
ied histone mark—H3K122ac, catalyzed
by EP300/CREBBP—is found at active en-
hancers in the MCF7 human breast cancer
cell line (Tropberger et al. 2013). The
KAT2A (GCN5)/KAT2B (PCAF) containing
the ATAC complex has also been shown
to be bound at enhancers—both those
marked by EP300 and those that are EP300
independent (Krebs et al. 2011). Although
in this later case a histone substrate for the
HAT activity of ATAC was not defined at
the enhancers, these studies, together with
our data, all point to a much broader role
for histone acetylation and for different
HATs in long-range gene regulation.
Methods
Cell culture
46c (Sox1-GFP) ESCs (Ying et al. 2003)
were cultivated without feeders in 10%
FCS and differentiated into neural pro-
genitor cells (NPCs), essentially as de-
scribed previously (Pollard et al. 2006). On
day 0 of differentiation, 46c cells were
seeded onto gelatinized dishes in N2B27
medium (0.53 B27supplement, 0.53 N2
supplement, 0.2 mM L-glutamine,
0.1 mM b-mercaptoethanol, Neurobasal
medium:DMEM/F12 medium 1:1). Dif-
ferentiating cells were trypsinized on
day 5 and Sox1–GFP-positive+ cells were
isolated using FluorescenceActivatedCell
Sorting (FACS) on a BD FACSAriaII SORP
(BectonDickinson). BD FACSDiva software
(Version 6.1.3) was used to control the
instrument and analyze the data.
OS25 ESCs were cultured and dif-
ferentiated by LIF withdrawal for 1 d and
treatment with retinoic acid (RA) for 2 d
(Morey et al. 2007).
Chromatin immunoprecipitation
The specificity of the anti-H4K16ac anti-
body (cat# 07-329 Millipore) was tested
with a modified histone peptide array
(Supplemental Fig. S1A) as described previously (Pradeepa et al.
2012). Native ChIP and assessment by hybridization to custom
microarrays were as described previously (Eskeland et al. 2010a;
Pradeepa et al. 2012). For the studies in OS25 cells, the following
modifications were used to preserve histone acetylation levels.
Cells were treated for 2 min with Sirtinol (5 mM) prior to trypsi-
Figure 6. (Legend on next page)
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nization. Nuclei were prepared and suspended in NB-R containing
sodium Butyrate (5 mM) and Sirtinol (5 mM) (Sigma Aldrich).
Chromatin was digested with 70–100 Boehringer units of
MNase to obtain a chromatin ladder enriched in mono-, di-, and
trinucleosomes. Beadswerewashed 23withWashBuffer 1 (25mM
Tris at pH 8, 2 mMEDTA, 150mMNaCl, 0.05% Triton X-100 [v/v])
and 13 inWash Buffer 2 (25mMTris at pH 8, 2mMEDTA, 150mM
LiCl, 0.1% sodium deoxycholate [w/v]) and once in TE. Wash
buffers were supplemented with 5 mM Sodium Butyrate, 5 mM
Sirtinol, 250 mM PMSF, and complete Proteinase Inhibitors
(Roche). For undifferentiated 46c ESCs and day 5 NPC cells, native
ChIP was performed as above, with the exception that the sirtinol
treatment prior to trypsinization was omitted, and MNase digest
was performed with 15 Boehringer units of MNase/1 3 106 cells.
ChIP sequencing and analysis
ChIP-sequencing and image processing pipeline for OS25
H4K16ac was carried out at the Gene Pool sequencing facility
(University of Edinburgh). For 46c H4K16ac, sequencing data was
produced by The Danish National High-Throughput DNA-
sequencing Center. In addition, we obtained the following pub-
licly available data sets in SRA lite format from the Gene Expression
Omnibus (www.ncbi.nlm.nih.gov/geo/): ESC H3K4me1, H3K27ac,
H3K4me3, EP300, NPC H3K27ac (GSE24164) (Creyghton et al.
2010), NPC H3K4me1 (GSE11172) (Meissner et al. 2008), NPC
H3K4me3 (GSE12241) (Mikkelsen et al. 2007), and ESC KAT8
(GSE37268) (Li et al. 2012). SRA-lite format files were converted to
FASTQ using the SRA-toolkit fastq-dump tool, and all FASTQ files
were aligned to the NCBI mm9 genome assembly using Bowtie
(Langmead et al. 2009), allowing a maximum of two mismatches
per read. Only sequences that mapped to one location were kept.
Reads aligned for H4K16ac ChIP were, in millions; UD OS25 Input,
105; D3 Input 57; UD OS25 H4K16ac 79; D3 H4K16ac 36. UD 46c
Input 142, UD 46c H4K16ac 124, NPC Input 140, NPC H4K16ac
111. Peaks were detected using SICER (Zang et al. 2009), utilizing
MNase-digested ChIP input DNA as background control for
H4K16ac, and input DNA for KAT8 (window size, 200 bp; fragment
size, 150 bp; false discovery rate, 0.01, gap size H4K16ac, H3K4me1,
600 bp, H3K27ac, H3K4me3, 200 bp).Wiggle tracks were generated
in a WCB Edinburgh Galaxy server (http://galaxy.psu.edu/) using
a 200-bp window with a 20-bp step normalized to reads per million
reads per base pair (RPM/bp). DNAse I hypersensitive sites were
taken from the USCS Genome Browser mm9 (July 2007) assembly
from the UW ENCODE group (Sabo et al. 2004).
Tag density graphs over TSS and TES were generated us-
ing custom perl scripts, and normalized to RPM. TSS and TES were
downloaded from the mm9 ensembl61 build (February 2011).
Gene histone mark average profiles were generated using
custom perl scripts and the coverageBed utility of the BEDTools
suite, and normalized to RPM/bp. H4K16ac peak localization
throughout the genome was analyzed using the CEAS suite (Shin
et al. 2009).
For enhancer heatmaps, active enhancers were defined as
regions with overlapping peaks (at least 50 bp) of H3K4me1 and
H3K27ac (Creyghton et al. 2010), and inactive enhancers were
defined as H3K4me1 peaks that did not overlap any peak of
H3K27ac. The number of reads in 20 500-bpwindows65 kb around
the enhancer midpoint was determined using coverageBED, nor-
malized to reads per million, and clustered based on the sum of
windows for H4K16ac using the CreateTreeView Files in the WCB
Edinburgh Galaxy server, then visualized using the Java TreeView
(http://jtreeview.sourceforge.net/) using the same settings for each
heatmap.
Expression analysis
RNA was extracted from UD and D3 differentiated ESCs and ana-
lyzed by RT-PCR as described previously (Eskeland et al. 2010a).
Microarray data sets for UD ESC were generated using Illumina
Mouse WG-6 v2.0 Expression BeadChip. RNA was labeled using
the Total Prep RNA Amplification Kit (Ambion), and array hy-
bridization and data extraction were carried out by the Edinburgh
Wellcome Trust Clinical Research Facility. Probe intensities were
averaged across three biological replicates. The top 500 genes with
a detection P-value of <0.001 were used as a sample of active genes,
while the 500 genes with the lowest intensities and a detection
P-value of >0.9 were defined as a sample of inactive genes.
Differential expression between UD and D3 OS25s was an-
alyzed using Agilent whole mouse genome 4 3 44 k oligomi-
croarrays. TRIzol-extracted RNAwas Cy3 labeled using the Amino
Allyl Message Amp II kit (Ambion), hybridized to arrays, and
scanned using a NimbleGenMS200 scanner. Spot intensities were
extracted using an Array-Pro Analyzer, quantile normalization,
and calculation of log2 fold change, and adjusted P-values were
performed in Limma (Smyth et al. 2005). Genes differentially ex-
pressed with an adjusted P-value of <0.005 were used for H4K16ac
tag density analysis. For differential expression between 46c UD
ESCs and day 5 NPCs, RNA was extracted using a High Pure RNA
Isolation kit (Roche), Cy3 labeled as above, hybridized to an
Agilent whole mouse genome 8 3 60K oligomicroarray, and
scanned as above. Spot intensities were extracted using Agilent
Feature Extraction software version 11.5.1.1 and the data were
analyzed as above.
Western blotting
The 0.53 106 ESC, NPC, and D3 cells were washed in ice-cold PBS,
lysed in NP-40 lysis buffer at 4°C for 30 min, then boiled in SDS
loading dye. Proteins were loaded onto a 4%–20% gradient
polyacrylamide gel and transferred to a
Hybond-P membrane (GE Healthcare).
Membranes were probed with antibodies
to detect a H4K16ac (1: 10000, Mill-
pore) and aH3 (1:10000, Abcam). Blots
were detected using the ChemiGlow
West Chemiluminescence Substrate Kit
(Protein Simple) on an Image Quant
LAS4010 (Version 1, Build 1.0.0.52; GE
Healthcare).
FISH and image analysis
FISH for the analysis of chromatin com-
paction, image analysis, and statistical
Figure 6. H4K16ac peaks have enhancer activity. (A) H4K16ac/KAT8/H3K27ac/EP300/H3K4me1/
input and DHS profiles from ES cells in the 59 regulatory region upstream ofNanog. ChIP data are shown
as RPM per base pair (bp) in 200-bp sliding windows with a 20-bp step. DHS sites are shown as tag
density in a 150-bp window with a 20-bp step. Gray-shaded box indicates a genetically defined Nanog
enhancer that is used for luciferase assay. (B,C) H4K16ac, H3K27ac, H3K4me1, and H3K4me3 profiles
across enhancer downstream from (B) Gsx2 gene (AE3) and (C ) in an intragenic region of Otop3 (AE4).
ChIP data are shown as RPM per base pair (bp) in 200-bp sliding windows with a 20-bp step. DHS sites
are shown as tag density in a 150-bp window with a 20-bp step. Purple-shaded areas correspond to
regulatory regions with H4K16ac peaks but not H3K27ac, and these regions were cloned for enhancer
reporter assay (D). (D) Enhancer reporter assay for genetically defined enhancer of Nanog (Nanog), and
randomly chosen active enhancers based on H3K4me1 and H4K16ac peaks but not H3K27ac peaks
(AE1–AE4). Regions with putative inactive enhancers containing H3K4me1 peaks, but neither H3K27ac
nor H4K16ac (in AE1, in AE2) were also assayed. Empty vector pGL4.26 (Control) served as a negative
control. Firefly luciferase activity was normalized to transfection efficiency with Renilla luciferase activity
using pRL-TK, log2 fold change in luciferase activity was plotted with error bars showing standard error
of mean from two biological and eight technical replicates (n = 8).
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evaluation of mean-squared interprobe distances were as de-
scribed previously (Eskeland et al. 2010a). Details of fosmid
probes used are given in Supplemental Table S1.
Luciferase reporter assay
H4K16ac +ve putative enhancer regions were PCR amplified from
E14 ESC genomic DNA (primer details in Supplemental Table S2)
and cloned into the pGL4.26 luciferase reporter plasmid (Promega).
Sequences of all clones were verified. The plasmids were then
cotransfectedwith pRL-TK into E14 ESCs using lipofectamine 2000
transfection reagent. Forty-eight hours after transfection, a Lucif-
erase assay was performed using the Dual-Luciferase Reporter As-
say System assay (Promega) as described by the manufacturer.
Data access
Microarray and ChIP-sequencing data for this study have been
submitted to the the NCBI Gene Expression Omnibus (GEO; http://
www.ncbi.nlm.nih.gov/geo/) under accession number GSE43103.
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